{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T19:10:09Z","timestamp":1739646609343,"version":"3.37.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2320-B-002-051"],"award-info":[{"award-number":["NSTC 113-2320-B-002-051"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Taiwan University School of Pharmacy Alumni Association in North America"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40801-024-00475-6","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T12:22:18Z","timestamp":1736338938000},"page":"105-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medication Hazards and Outcome Patterns of Pediatric Drug-Associated Liver Injury in Taiwan: An Analysis of 1998\u20132017 Spontaneous Adverse Drug Reaction Reports"],"prefix":"10.1007","volume":"12","author":[{"given":"Yu-Ting","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Ing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0579-8659","authenticated-orcid":false,"given":"Yunn-Fang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"475_CR1","first-page":"929","volume-title":"Yaffe and Aranda\u2019s neonatal and pediatric pharmacology: therapeutic principles in practice","author":"M Rieder","year":"2021","unstructured":"Rieder M, Elzagallaai A, Carleton B. Adverse drug reactions in newborns and children. In: Aranda JV, van den Anker JN, editors. Yaffe and Aranda\u2019s neonatal and pediatric pharmacology: therapeutic principles in practice. 5th ed. Philadelphia: Wolters Kluwer; 2021. p. 929\u201340.","edition":"5"},{"key":"475_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s0022-3476(68)80414-7","volume":"72","author":"HC Shirkey","year":"1968","unstructured":"Shirkey HC. Therapeutic orphans. J Pediatr. 1968;72:119\u201320. https:\/\/doi.org\/10.1016\/s0022-3476(68)80414-7.","journal-title":"J Pediatr"},{"issue":"12","key":"475_CR3","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1111\/bcp.14958","volume":"88","author":"A Smits","year":"2022","unstructured":"Smits A, Annaert P, Cavallaro G, De Cock PAJG, de Wildt SN, Kindblom JM, et al. Current knowledge, challenges and innovations in developmental pharmacology: a combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper. Br J Clin Pharmacol. 2022;88(12):4965\u201384. https:\/\/doi.org\/10.1111\/bcp.14958.","journal-title":"Br J Clin Pharmacol"},{"key":"475_CR4","first-page":"445","volume-title":"Nelson textbook of pediatrics","author":"TL Sandritter","year":"2020","unstructured":"Sandritter TL, Jones BL, Kearns GL, et al. Principles of drug therapy. In: Kliegman RM, St Geme JW, editors., et al., Nelson textbook of pediatrics. 21st ed. Philadelphia: Elsevier; 2020. p. 445\u201356.","edition":"21"},{"key":"475_CR5","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1002\/psp4.13045","volume":"12","author":"YT Huang","year":"2023","unstructured":"Huang YT, Huang YM, Kung FL, Lin CJ, Jao T, Ho YF. Physiologically based mechanistic insight into differential risk of valproate hepatotoxicity between children and adults: a focus on ontogeny impact. CPT Pharmacometrics Syst Pharmacol. 2023;12:1960\u201371. https:\/\/doi.org\/10.1002\/psp4.13045.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"5","key":"475_CR6","doi-asserted-by":"publisher","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","volume":"116","author":"NP Chalasani","year":"2021","unstructured":"Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR, Practice Parameters Committee of the American College of Gastroenterology. ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2021;116(5):878\u201398. https:\/\/doi.org\/10.14309\/ajg.0000000000001259.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"475_CR7","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","volume":"70","author":"European Association for the Study of the Liver","year":"2019","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: drug-induced liver injury. J Hepatol. 2019;70(6):1222\u201361. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.014.","journal-title":"J Hepatol"},{"issue":"4","key":"475_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/MPG.0000000000003535","volume":"75","author":"F Monge-Urrea","year":"2022","unstructured":"Monge-Urrea F, Montijo-Barrios E. Drug-induced liver injury in pediatrics. J Pediatr Gastroenterol Nutr. 2022;75(4):391\u20135. https:\/\/doi.org\/10.1097\/MPG.0000000000003535.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"475_CR9","unstructured":"Taiwan National Adverse Drug Reactions Reporting System. Available from: https:\/\/www.fda.gov.tw\/tc\/siteContent.aspx?sid=4240."},{"issue":"4","key":"475_CR10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s11096-018-0698-5","volume":"40","author":"JH Ye","year":"2018","unstructured":"Ye JH, Ho YF, On AW, Chen WW, Huang YM, Huang WI, Tang YW. Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone. Int J Clin Pharm. 2018;40(4):911\u201320. https:\/\/doi.org\/10.1007\/s11096-018-0698-5.","journal-title":"Int J Clin Pharm"},{"key":"475_CR11","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC)\/Defined Daily Dose (DDD) Index. https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed Oct 1, 2023."},{"key":"475_CR12","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Introductory guide for Standardised MedDRA Queries (SMQs) version 24.1. Available from: https:\/\/admin.meddra.org\/sites\/default\/files\/guidance\/file\/000595_SMQ_intguide_24_1.pdf, 2021. Accessed Sep 20, 2023."},{"key":"475_CR13","unstructured":"Micromedex. Merative US L.P. 2023. Available from: https:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/ssl\/true. Accessed Dec 31, 2023."},{"issue":"12","key":"475_CR14","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/pds.4115","volume":"25","author":"JH Scholl","year":"2016","unstructured":"Scholl JH, van Puijenbroek EP. The value of time-to-onset in statistical signal detection of adverse drug reactions: a comparison with disproportionality analysis in spontaneous reports from the Netherlands. Pharmacoepidemiol Drug Saf. 2016;25(12):1361\u20137. https:\/\/doi.org\/10.1002\/pds.4115.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"475_CR15","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/BF03262002","volume":"35","author":"L Aagaard","year":"2012","unstructured":"Aagaard L, Strandell J, Melskens L, Petersen PSG, Hansen EH. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase\u2122. Drug Saf. 2012;35(12):1171\u201382. https:\/\/doi.org\/10.1007\/BF03262002.","journal-title":"Drug Saf"},{"issue":"5","key":"475_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1365-2125.2010.03754.x","volume":"70","author":"C Ferrajolo","year":"2010","unstructured":"Ferrajolo C, Capuano A, Verhamme KM, Schuemie M, Rossi F, Stricker BH, et al. Drug-induced hepatic injury in children: a case\/non-case study of suspected adverse drug reactions in VigiBase. Br J Clin Pharmacol. 2010;70(5):721\u20138. https:\/\/doi.org\/10.1111\/j.1365-2125.2010.03754.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"475_CR17","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s40264-018-0706-7","volume":"41","author":"C Tieu","year":"2018","unstructured":"Tieu C, Breder CD. A critical evaluation of safety signal analysis using algorithmic standardised MedDRA queries. Drug Saf. 2018;41(12):1375\u201385. https:\/\/doi.org\/10.1007\/s40264-018-0706-7.","journal-title":"Drug Saf"},{"issue":"2","key":"475_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MPG.0000000000002383","volume":"69","author":"F DiPaola","year":"2019","unstructured":"DiPaola F, Molleston JP, Gu J, Cirulli ET, Chalasani N, Barnhart H, et al. US Drug Induced Liver Injury Network. Antimicrobials and antiepileptics are the leading causes of idiosyncratic drug-induced liver injury in American children. J Pediatr Gastroenterol Nutr. 2019;69(2):152\u20139. https:\/\/doi.org\/10.1097\/MPG.0000000000002383.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"475_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2020.100580","volume":"92","author":"K Sridharan","year":"2020","unstructured":"Sridharan K, Daylami AA, Ajjawi R, Ajooz HAMA. Drug-induced liver injury in critically ill children taking antiepileptic drugs: a retrospective study. Curr Ther Res Clin Exp. 2020;92: 100580. https:\/\/doi.org\/10.1016\/j.curtheres.2020.100580.","journal-title":"Curr Ther Res Clin Exp"},{"key":"475_CR20","unstructured":"LiverTox: clinical and research information on drug-induced liver injury. Liver Disease Research Branch of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Library of Medicine (NLM), National Institutes of Health. Available from: https:\/\/livertox.nih.gov. Accessed Jan 2, 2024."},{"issue":"8","key":"475_CR21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1080\/14740338.2024.2368817","volume":"23","author":"M Fusaroli","year":"2024","unstructured":"Fusaroli M, Raschi E, Poluzzi E, Hauben M. The evolving role of disproportionality analysis in pharmacovigilance. Expert Opin Drug Saf. 2024;23(8):981\u201394. https:\/\/doi.org\/10.1080\/14740338.2024.2368817.","journal-title":"Expert Opin Drug Saf"},{"key":"475_CR22","unstructured":"Taiwan Pediatric Oncology Group. TPOG-OS 2017. Available from: https:\/\/tpog.ccfroc.org.tw\/TPOG\/TPOG_BC_2017_V4.1%20_2020_11_16_with%20tables.pdf. Accessed Dec 31, 2023."},{"issue":"2","key":"475_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/pbc.26142","volume":"64","author":"MJ Li","year":"2017","unstructured":"Li MJ, Liu HC, Yen HJ, Jaing TH, Lin DT, Yang CP, et al. Treatment for childhood acute lymphoblastic leukemia in Taiwan: Taiwan Pediatric Oncology Group ALL-2002 study emphasizing optimal reinduction therapy and central nervous system preventive therapy without cranial radiation. Pediatr Blood Cancer. 2017;64(2):234\u201341. https:\/\/doi.org\/10.1002\/pbc.26142.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"475_CR24","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/hep.24527","volume":"54","author":"H Devarbhavi","year":"2011","unstructured":"Devarbhavi H, Karanth D, Prasanna KS, Adarsh CK, Patil M. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents. Hepatology. 2011;54(4):1344\u201350. https:\/\/doi.org\/10.1002\/hep.24527.","journal-title":"Hepatology"},{"issue":"8","key":"475_CR25","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/children9081136","volume":"9","author":"I Dijm\u0103rescu","year":"2022","unstructured":"Dijm\u0103rescu I, Gu\u021b\u0103 OM, Brezeanu LE, Dijm\u0103rescu AD, Becheanu CA, P\u0103curar D. Drug-induced hepatitis in children: the experience of a single center in Romania. Children (Basel). 2022;9(8):1136. https:\/\/doi.org\/10.3390\/children9081136.","journal-title":"Children (Basel)."},{"issue":"7","key":"475_CR26","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1124\/dmd.115.068593","volume":"44","author":"NC Sadler","year":"2016","unstructured":"Sadler NC, Nandhikonda P, Webb-Robertson BJ, Ansong C, Anderson LN, Smith JN, et al. Hepatic cytochrome P450 activity, abundance, and expression throughout human development. Drug Metab Dispos. 2016;44(7):984\u201391. https:\/\/doi.org\/10.1124\/dmd.115.068593.","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"475_CR27","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1124\/dmd.115.066639","volume":"44","author":"CY Li","year":"2016","unstructured":"Li CY, Renaud HJ, Klaassen CD, Cui JY. Age-specific regulation of drug-processing genes in mouse liver by ligands of xenobiotic-sensing transcription factors. Drug Metab Dispos. 2016;44(7):1038\u201349. https:\/\/doi.org\/10.1124\/dmd.115.066639.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"475_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/cts.12683","volume":"13","author":"YF Ho","year":"2020","unstructured":"Ho YF, Hu FC, Lee PI. The advantages and challenges of using real-world data for patient care. Clin Transl Sci. 2020;13(1):4\u20137. https:\/\/doi.org\/10.1111\/cts.12683.","journal-title":"Clin Transl Sci"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-024-00475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-024-00475-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-024-00475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T18:28:00Z","timestamp":1739644080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-024-00475-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1007\/s40801-024-00475-6","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"type":"print","value":"2199-1154"},{"type":"electronic","value":"2198-9788"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"9 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by the National Science and Technology Council, Executive Yuan, Taipei, Taiwan, R.O.C. (NSTC 113-2320-B-002-051) and supported by the National Taiwan University School of Pharmacy Alumni Association in North America. The funder\/sponsor did not participate in the work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The local ethics committee approved the study (NTUH REC 202407169RINA).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The datasets in the current study are available from the corresponding author upon reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Y.T.H. designed the study, performed data analysis, and drafted the initial manuscript. Y.M.H. designed the study, interpreted study findings, and revised the manuscript. N.C.L. interpreted the results and reviewed and revised the manuscript. P.I.L. conceptualized the study, interpreted the results, and reviewed and revised the manuscript for important intellectual content. Y.F.H. conceptualized and designed the study, supervised data collection and analysis, and drafted and finalized the manuscript. All authors contributed to and approved the final manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}